Browse > Article

Evaluation of Nigella sativa Seed Constituents for Their in vivo Toxicity in Mice  

EI-Hadiyah, T.M. (Department of Pharmacology, College of Pharmacy, King Saud University)
Raza, M. (Department of Pharmacology, College of Pharmacy, King Saud University)
Mohammed, O.Y. (College of Pharmacy, Khartoum University)
Abdallah, A.A. (College of Pharmacy, Khartoum University)
Publication Information
Natural Product Sciences / v.9, no.1, 2003 , pp. 22-27 More about this Journal
Abstract
This study was designed to investigate the effects of main constituents of Nigella sativa (NS) seed on the survival and CNS responses in experimental animals. The toxicological investigations were conducted for the determination of median lethal doses $(LD_{50})$ of NS seed constituents [i.e. aqueous extract (AE), fixed oil (FO), volatile oil (VO)] and main components of its VO [i.e. thymoquinone (TQ), ${\alpha}-pinene$ (AP) and p-cymene (PC)]. A part of this study includes evaluation NS constituents in the induction of minimal neurological deficit (MND) as a parameter for neurotoxicity using chimney test. In this study, the i.p. $LD_{50}$ values of AE, FO, VO, TQ (suspended In 0.5%CMC), TQ (dissolved in corn oil), AP and PC, were 3020, 3371, 1853, 616.6, 90.3, 1726 and 1523 mg/kg, respectively. All the NS constituents can be considered moderately toxic ($LD_{50}$ ranged from 616.6 to 3371 mg/kg), except the oily solution of TQ, which was very toxic ($LD_{50}$ was 90.3 mg/kg). It appeared that the toxicity of the whole VO is mainly due to its content of TQ and to some extent PC. All the NS constituents induced different degrees of MND at certain dose levels. The median neurotoxic (or sedating) doses $(TD_{50})$ of AE, FO, VO, TQ (suspended in CMC) and AP and PC, were 950, 1403, 306, 88.1, >173 and 368 mg/kg, respectively. TQ was the most potent component in inducing MND, whereas the FO and AE were the least. Neurotoxicity induced by the VO in the chimney test may refer basically to its contents of TQ and to some extent PC and AP.
Keywords
Nigella sativa; thymoquinone; fixed oil; volatile oil; ${\alpha}-pinene$; p-cymene; $LD_{50}$;
Citations & Related Records

Times Cited By SCOPUS : 1
연도 인용수 순위
1 Al Jassir, M. S. Chemical composition and microflora of black cumin (Nigella sativa) seeds growing in Saudi Arabia. Food Chemistry, 45, 239-242 (1992)   DOI   ScienceOn
2 Canonica, L., Jomoni, G., Scolastico and Bonati, A. The pharmacologically active principle in Nigella sativa. Gazz. Chem. Ital., 93, 1404-1407 (1963)
3 EI Tahir, K.E.H. The medicinal effect of some vegetable oils and animal fats. A guide to the ideal healthy edible oil. Riyadh. (In Arabic) (1998)
4 Houghton, P.J., Zaka, R., Hera, P.D. and Hoult, J.R.S. Fixed oil of Nigella sativa and derived thymoquinone inhibit eicosanoid generation in leukocytes and membrane lipid peroxidation. Planta Medica, 61, 33-36 (1995)   DOI   ScienceOn
5 Merk index $12^{th}$ edition, published by Merk research laboratories, USA. Merk and Co., lNC., Whitehouse station, N.J., USA (1996)
6 AbouBasha, L.I., Rashed, M.S. and Aboua-Enein,Y. TLC assay of thymoquinone in black seed oil (Nigella sativa) and identification of dithymoquinone and thymol. J. Liq. Chromatogr. 18, 105-115 (1995)   DOI
7 Akhtar, A.M., Ahmad, K.D., Gilani, S.N. and Nazir, A. Antiulcer effects of aqueous extracts of Nigella sativa and Pongamia pinnata in rats. Fitoterapia. 57, 195-199 (1996)
8 Al Hader, A., Agel, M. and Hassan, Z. Hypoglycemic effects of the volatile oil of Nigella sativa seeds. Int. J. Pharmacog. 13, 96-100 (1993)
9 Al Awadi F, Fatania H, Shamte U. The effect of a plants mixture extract on liver gluconeogenesis in streptozotocin induced diabetic rats. Diabetes Res. 18(4), 163-8 (1991)
10 Aboutabl, E.A., El-azzouny, A.A. and Hammerschmidt, F.J. Aroma volatile of Nigella sativa seeds. Prog Essent., Oil Res. Proc. Int. Symp. Essent. Oils $16^{th}$, 49-55. (1986)
11 Rathee, P.S., Mishra, S.H. and Kaushal, R. Antimicrobial activity of essential oil, fixed oil and unsaponifiable matter of Nigella sativa. Indian J. Pharm. Sci., 44, 8-10 (1982)
12 Ghosheh OA, Houdi AA, Crooks PA. High performance liquid chromatographic analysis of the pharmacologically active quinones and related compounds in the oil of the black seed (Nigella sativa L.). J Pharm Biomed Anal. 19(5), 757-62 (1999)   DOI   ScienceOn
13 Litchfield J., and Wilcoxon F.A simplified method for evaluating dose-effect experiments. J. Pharmacol. Exp. Ther., 257, 20-31. (1949)
14 Babayan, V.K. Kootungal, D. and Halaby, G.A Proximate analysis, fatty acid and amino acid composition of Nigella sativa seeds. J. Food Sci. 43, 1314-1315 (1978)   DOI
15 Badary O., AI-Shabanah O., Nagi, M., AI-Bekairi, A. and Elmazar, M. Acute and subchronic toxicity of thymoquinone in mice. Drug Develop Res. 44, 56-61 (1998)   DOI   ScienceOn
16 Nagi, M., Alam, K., Badary, O., Al-Shabanah, O., Al-Sawaf, H., and Al-Bekairi, A. Thymoquinone protects against carbon tetrachloride hepatotoxicity in mice via an antioxidant mechanism. Biochem. Mol. BioI. Int., 47, 153-159 (1999)
17 Chakravarty, N. Inhibition of histamine release from mast cells by Nigellone. Ann. Allergy, 70, 237-242 (1993)   PUBMED
18 Boissier, J.R., Tardy, J. and Diverres, J.C. A novel simple test for tranquilizing activity: The chimny test. Med. Exp. Basel, 3, 81-84 (1960)   DOI
19 EI-Alfy, TS, EI-Fatatry, HE, Toama, MA High performance liquid chromatographic analysis of the pharmacologically active quinines and related compounds in the oil of the black seeds (Nigella sativa L.). Pharmazie, 30, 109 (1975)
20 Mahfouz, M. and EI-Dakhakhny, M. The isolation of a crystalline active principle from Nigella sativa seeds. J. Pharm. Sci. UAR., 1, 9-19 (1960)
21 Khanna, T., Zaidi, F.A. and Dandiyn, P.C. CNS and analgesic studies on Nigella sativa. Fitoterapia, 64, 407-410 (1993)
22 EI Tahir, K.E.H., Ashour, M.M. and Al Harbi, M.M. The cardiovascular actions of the volatile oil of the black seed (Nigella sativa) in rats. Elucidation of the mechanism of action. Gen. Pharmacol., 24, 1123-1131 (1993)   DOI   ScienceOn
23 EI Dakhakhny, M. Studies on the chemical constitution of Egyptian Nigella sative L. Seeds. Pharmazie, 30,109-111 (1963)
24 Hag, A., Al Tufail, M., Lobo, P.I., Khabar, K.S.A., Sheth, K.V. and AI-Sedairy, S.T. Polymorphnuclear leukocyte phagocytic activity. Immunopharmacology, 30, 147-155 (1995)   DOI   ScienceOn
25 Abdel-Fattah,A.M., Matsumoto, K. and Watanabe, H., Antinociceptive effects of Nigella sativa oil and its major component, thymoquinone, in mice. Eur. J. Pharmacol. 14, 400,89-97 (2000)
26 El Kadi, A. and Kandil, O. Effect of Nigella sativa (the black seed). In proceedings of the $4^{th}$ International conference on Islamic medicine, Karachi, Pakistan (1986)
27 Klaassen, C. and Doull, J. Evaluation of safety: Toxicologic evaluation. In: Toxicology, the basic science of poisons. Editors: Klaassen, C., Doull, J. and Amdur, M.O., Macmillan publishing co. inc., pp. 11-27. (1980)
28 EI Fatatry HM. Isolation and structure assignment of an antimicrobial principle from the volatile oil of Nigella sativa L. seeds. Pharmazie, 30(2), 109-11 (1975)
29 EI Tahir, K.E.H., Al Tahir, A Y. and Ageel, A.M. Pharmacological studies on Sesame and Nigella sativa fixed oils: effects on the sensitivities of the adrenoceptors, baroreceptors, platelets and uterus of the rat. Saudi Pharm. J., 7, 205-215 (1999)
30 Hashim, F.M. and EI-Kiey, M.A. Nigella sativa seeds of Egypt. J. Pharm. Sci. UAR, 3, 121-133 (1962)
31 Sayed, M. D. Traditional medicine in health care. J. Ethnopharmacol., 2, 19-22 (1980)   DOI   PUBMED   ScienceOn
32 Nergiz, C. and Otles, S. Chemical composition of Nigella sativa seeds. Food Chemistry, XX, 259-261 (1993)